GIGLIO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 337
EU - Europa 262
AS - Asia 38
OC - Oceania 1
Totale 638
Nazione #
US - Stati Uniti d'America 337
IE - Irlanda 92
SE - Svezia 69
CN - Cina 30
UA - Ucraina 30
IT - Italia 27
DE - Germania 25
FI - Finlandia 11
SG - Singapore 6
GB - Regno Unito 5
CZ - Repubblica Ceca 2
IN - India 2
AT - Austria 1
AU - Australia 1
Totale 638
Città #
Dublin 92
Chandler 89
Jacksonville 60
Nyköping 39
Dearborn 29
Beijing 17
Princeton 13
Medford 12
Cambridge 11
Boardman 10
Des Moines 9
Ashburn 8
New York 6
Wilmington 5
Singapore 4
Hefei 3
Messina 3
Milan 3
Reggio Calabria 3
Woodbridge 3
Ann Arbor 2
Brno 2
Hebei 2
Nordhastedt 2
Rome 2
Washington 2
Bremen 1
Carrara 1
Fuzhou 1
Hanover 1
Hyderabad 1
Jinan 1
Mesagne 1
Nanjing 1
Nanning 1
Norwalk 1
Pune 1
Seattle 1
Serra 1
Shenyang 1
Soverato Marina 1
Taizhou 1
Tappahannock 1
Vienna 1
Totale 449
Nome #
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 67
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 57
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery 56
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 51
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 50
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 50
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 46
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 46
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 44
Sintesi e valutazione di derivati 2,4-tiazolidindionici non carbossilici come inibitori dell'aldoso reduttasi 41
Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications 39
SIMPLE MICROWAVE-ASSISTED LIGAND-FREE SUZUKI CROSS-COUPLING: FUNCTIONALIZATION OF HALO-PYRIMIDINE MOIETIES 37
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD-Manager): Study protocol for a pilot randomised controlled trial 11 Medical and Health Sciences 1117 Public Health and Health Services 32
Designing a mHealth clinical decision support system for Parkinson's disease: A theoretically grounded user needs approach 25
Totale 641
Categoria #
all - tutte 2.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 16 7 0 4 8 21 23 12 1 8 13 0
2020/202169 12 0 10 7 0 11 0 7 0 8 7 7
2021/202257 0 1 2 0 1 0 10 3 1 0 9 30
2022/2023271 16 30 10 28 23 25 2 18 108 1 8 2
2023/202472 1 18 4 9 10 14 1 8 2 1 0 4
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 641